STARRETT (L.S.) CO -CL A (SCX) Stock Fundamental Analysis

NYSE:SCX • US8556681091

16.18 USD
+0.01 (+0.06%)
Last: May 22, 2024, 08:04 PM
Fundamental Rating

5

Taking everything into account, SCX scores 5 out of 10 in our fundamental rating. SCX was compared to 131 industry peers in the Machinery industry. While SCX has a great health rating, its profitability is only average at the moment. SCX has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • SCX had positive earnings in the past year.
  • In the past year SCX had a positive cash flow from operations.
  • Of the past 5 years SCX 4 years were profitable.
  • SCX had a positive operating cash flow in 4 of the past 5 years.
SCX Yearly Net Income VS EBIT VS OCF VS FCFSCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

1.2 Ratios

  • The Return On Assets of SCX (10.38%) is better than 83.08% of its industry peers.
  • The Return On Equity of SCX (14.81%) is better than 70.00% of its industry peers.
  • SCX has a Return On Invested Capital (7.46%) which is in line with its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for SCX is in line with the industry average of 10.17%.
Industry RankSector Rank
ROA 10.38%
ROE 14.81%
ROIC 7.46%
ROA(3y)9.28%
ROA(5y)3.69%
ROE(3y)16.98%
ROE(5y)2.17%
ROIC(3y)10.36%
ROIC(5y)7.65%
SCX Yearly ROA, ROE, ROICSCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40

1.3 Margins

  • Looking at the Profit Margin, with a value of 7.72%, SCX is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
  • SCX has a Operating Margin of 5.64%. This is comparable to the rest of the industry: SCX outperforms 41.54% of its industry peers.
  • SCX's Operating Margin has improved in the last couple of years.
  • SCX has a Gross Margin of 31.48%. This is comparable to the rest of the industry: SCX outperforms 57.69% of its industry peers.
  • In the last couple of years the Gross Margin of SCX has remained more or less at the same level.
Industry RankSector Rank
OM 5.64%
PM (TTM) 7.72%
GM 31.48%
OM growth 3Y77.51%
OM growth 5Y28.1%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.42%
GM growth 5Y0.19%
SCX Yearly Profit, Operating, Gross MarginsSCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SCX is creating some value.
  • The number of shares outstanding for SCX has been increased compared to 1 year ago.
  • SCX has a better debt/assets ratio than last year.
SCX Yearly Shares OutstandingSCX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
SCX Yearly Total Debt VS Total AssetsSCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

  • SCX has an Altman-Z score of 4.24. This indicates that SCX is financially healthy and has little risk of bankruptcy at the moment.
  • SCX's Altman-Z score of 4.24 is fine compared to the rest of the industry. SCX outperforms 71.54% of its industry peers.
  • SCX has a debt to FCF ratio of 0.50. This is a very positive value and a sign of high solvency as it would only need 0.50 years to pay back of all of its debts.
  • The Debt to FCF ratio of SCX (0.50) is better than 91.54% of its industry peers.
  • A Debt/Equity ratio of 0.02 indicates that SCX is not too dependend on debt financing.
  • SCX's Debt to Equity ratio of 0.02 is amongst the best of the industry. SCX outperforms 82.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.5
Altman-Z 4.24
ROIC/WACC0.81
WACC9.21%
SCX Yearly LT Debt VS Equity VS FCFSCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 3.11 indicates that SCX has no problem at all paying its short term obligations.
  • SCX has a better Current ratio (3.11) than 76.15% of its industry peers.
  • SCX has a Quick Ratio of 1.42. This is a normal value and indicates that SCX is financially healthy and should not expect problems in meeting its short term obligations.
  • SCX's Quick ratio of 1.42 is fine compared to the rest of the industry. SCX outperforms 63.85% of its industry peers.
Industry RankSector Rank
Current Ratio 3.11
Quick Ratio 1.42
SCX Yearly Current Assets VS Current LiabilitesSCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2

3. Growth

3.1 Past

  • SCX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.20%, which is quite impressive.
  • Looking at the last year, SCX shows a decrease in Revenue. The Revenue has decreased by -2.50% in the last year.
  • SCX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.44% yearly.
EPS 1Y (TTM)33.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.51%
Revenue 1Y (TTM)-2.5%
Revenue growth 3Y8.33%
Revenue growth 5Y3.44%
Sales Q2Q%-7.04%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SCX Yearly Revenue VS EstimatesSCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

5

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 6.32, the valuation of SCX can be described as very cheap.
  • Based on the Price/Earnings ratio, SCX is valued cheaper than 95.38% of the companies in the same industry.
  • SCX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.19.
Industry RankSector Rank
PE 6.32
Fwd PE N/A
SCX Price Earnings VS Forward Price EarningsSCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SCX is valued cheaper than 91.54% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, SCX is valued cheaply inside the industry as 96.92% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.15
EV/EBITDA 5.98
SCX Per share dataSCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • SCX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

STARRETT (L.S.) CO -CL A

NYSE:SCX (5/22/2024, 8:04:00 PM)

16.18

+0.01 (+0.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-06
Earnings (Next)09-13
Inst Owners0.39%
Inst Owner Change0%
Ins Owners1.65%
Ins Owner Change0%
Market Cap121.51M
Revenue(TTM)251.67M
Net Income(TTM)19.43M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.32
Fwd PE N/A
P/S 0.48
P/FCF 8.15
P/OCF 4.38
P/B 0.93
P/tB 0.97
EV/EBITDA 5.98
EPS(TTM)2.56
EY15.82%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.99
FCFY12.27%
OCF(TTM)3.69
OCFY22.81%
SpS33.51
BVpS17.46
TBVpS16.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 10.38%
ROE 14.81%
ROCE 9.41%
ROIC 7.46%
ROICexc 7.75%
ROICexgc 8.08%
OM 5.64%
PM (TTM) 7.72%
GM 31.48%
FCFM 5.93%
ROA(3y)9.28%
ROA(5y)3.69%
ROE(3y)16.98%
ROE(5y)2.17%
ROIC(3y)10.36%
ROIC(5y)7.65%
ROICexc(3y)11.22%
ROICexc(5y)8.32%
ROICexgc(3y)11.72%
ROICexgc(5y)8.76%
ROCE(3y)13.07%
ROCE(5y)9.65%
ROICexgc growth 3Y86.71%
ROICexgc growth 5Y30.58%
ROICexc growth 3Y87.08%
ROICexc growth 5Y32.25%
OM growth 3Y77.51%
OM growth 5Y28.1%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.42%
GM growth 5Y0.19%
F-Score6
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.5
Debt/EBITDA 0.15
Cap/Depr 199.08%
Cap/Sales 5.09%
Interest Coverage 12.47
Cash Conversion 134.39%
Profit Quality 76.76%
Current Ratio 3.11
Quick Ratio 1.42
Altman-Z 4.24
F-Score6
WACC9.21%
ROIC/WACC0.81
Cap/Depr(3y)116.97%
Cap/Depr(5y)119.33%
Cap/Sales(3y)3.09%
Cap/Sales(5y)3.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.51%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.5%
Revenue growth 3Y8.33%
Revenue growth 5Y3.44%
Sales Q2Q%-7.04%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-39.78%
EBIT growth 3Y92.3%
EBIT growth 5Y32.51%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y256.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1255.04%
OCF growth 3YN/A
OCF growth 5Y43.93%

STARRETT (L.S.) CO -CL A / SCX FAQ

Can you provide the ChartMill fundamental rating for STARRETT (L.S.) CO -CL A?

ChartMill assigns a fundamental rating of 5 / 10 to SCX.


What is the valuation status of STARRETT (L.S.) CO -CL A (SCX) stock?

ChartMill assigns a valuation rating of 5 / 10 to STARRETT (L.S.) CO -CL A (SCX). This can be considered as Fairly Valued.


How profitable is STARRETT (L.S.) CO -CL A (SCX) stock?

STARRETT (L.S.) CO -CL A (SCX) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for SCX stock?

The Price/Earnings (PE) ratio for STARRETT (L.S.) CO -CL A (SCX) is 6.32 and the Price/Book (PB) ratio is 0.93.